# Guangzhou PharmaLab Co., Ltd. – FDA Inspection, Aug 30, 2023

Source: https://www.keypedia.com/records/fda_inspections/guangzhou-pharmalab-co-ltd/bbd007e9-3faf-47cd-8efd-d46eb63ca88c
Source feed: FDA_Inspections

> FDA inspection 1217730 of Guangzhou PharmaLab Co., Ltd., August 30, 2023. Classification: Official Action Indicated (OAI). 2 citations under 21 CFR part 211. Form 483 issued.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217730
- Company Name: Guangzhou PharmaLab Co., Ltd.
- Inspection Date: 2023-08-30
- Classification: Official Action Indicated (OAI)
- Classification Code: OAI
- Center: Human Drugs
- Office Name: Office of Inspections and Investigations
- Citation Count: 2

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/hung-h-do/580f78ba-ed7a-4c10-8f4c-a99d0af7206e)
- [Issuing Officer](https://www.keypedia.com/people/rowena-s-nguyen/ae39318e-1653-467c-94cc-26f8929441ac)

Company: https://www.keypedia.com/companies/guangzhou-pharmalab-co-ltd/61032ac2-8cc8-4c4f-95a9-32c49679642b

Office: https://www.keypedia.com/offices/office-of-inspections-and-investigations/7dd0b904-a3df-46bc-a7b2-70ddb6f809c8